Obesity: A Disease is the official OMA podcast exploring the many facets of the disease of obesity. Episodes provide valuable insights into this growing problem and better equip clinicians to understand and engage in treating this disease.
Clinical Conversations
In these short podcast episodes, experts in the field of obesity medicine share their expertise on current topics relevant to the understanding and treatment of the disease of obesity, as well as how obesity effects other related comorbidities.
Article Reviews
Guests in these episodes unpack and review current research articles in the field of obesity in a convenient and quickly digestible format.
Start Listening Today
Subscribe on Your Favorite Podcast Platform
Find Obesity: A Disease on your preferred podcast platform. The OMA podcast episodes are great for hearing from industry experts in obesity medicine on current topics and staying up to date on obesity research in a high level, easily accessible format.
In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings interviews, Dr. Michelle Look, a highlighted speaker from the Obesity Medicine 2023 Conference, Early Intervention in Weight Management: Treating Pre-Obesity. Topics covered will include identifying the risks associated with pre-obesity, best practices for screening and taking a weight history, and reviewing practical treatment strategies to halt the progression of the disease.
Episode Guests
Michelle Look, MD, FAAFP
Related Resources
https://academy.obesitymedicine.org/content/overcoming-obesity-2023-early-intervention-weight-management-treating-pre-obesity-recorded#group-tabs-node-course-default1
In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1 medications.
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org.
In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Episode Guests
Dr. Shagun Bindlish, MD
Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Related Resources
Obesity Pillars®
In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist and is also a co-author of the OMA Pediatric Obesity Clinical Practice Statements. Dr. O’Hara is an ABOM certified obesity specialist and the medical director of the WOW 4 Wellness Clinic. Today’s topics are foundational therapies, shared decision making, off-label treatment and pharmacotherapy treatment options in pediatrics.
Episode Guests
Dr. Suzanne Cuda
Nancy Browne
Dr. Valarie O’Hara
Related Resources
Pediatric Obesity Algorithm®
OMA Pediatric Resources Webpage
OMA Blog
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org.
In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Episode Guests
Dr. Shagun Bindlish, MD
Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Related Resources
Obesity Pillars®
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In addition to his rich contribution to the medical literature, he is an author of several best-selling books, and a passionate advocate for promoting metabolic health and nutrition especially with respect to the health risks of sugar. He was the keynote speaker at the OMA’s 2022 Fall Obesity Summit. His presentation was titled ” The BIG Picture: NAFLD, the sentinel disease of metabolic syndrome”. Topics discussed include the health consequences of sugar consumption, the prevalence of NAFLD, diagnosing NAFLD, and treatment through medication, nutrition, and weight loss.
Episode Guests
Dr. Nick Pennings, DO, FOMA
Dr. Robert Lustig, MD
Resources Mentioned
Fat Chance and Metabolical, by Dr. Lustig
Related Resources
Overcoming Obesity Conference
Obesity Algorithm®
Obesity Medicine Association Blog
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts.
In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Episode Guests
Tiffany Lowe-Clayton, DO
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Related Resources
Obesity Pillars Journal
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate lifestyle interventions to each of the four key phenotypes that explain about eighty-five percent of patients with obesity. Andreas Acosta, MD, PhD is an assistant professor in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, MN. Dr. Acosta presented his exciting research at the OMA Fall 2022 Obesity Summit in Anaheim, CA, in a presentation titled “Phenotype-Guided Lifestyle Intervention for Obesity Management"
Topics discussed include hungry gut, emotional eater, and slow metabolizer phenotypes. Additional topics include overlapping phenotypes, phenotype profiling, and treatment approaches.
Episode Guests
Andreas Acosta, MD, PhD
Nicholas Pennings, DO, FOMA, FACOFP
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts.
In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Episode Guests
Tiffany Lowe-Clayton, DO
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Related Resources
Obesity Pillars Journal